2-(Benzylsulfanyl)-6-chloro-9-isopropylpurine, a valuable intermediate in the synthesis of diaminopurine cyclin dependent kinase inhibitors

European Journal of Organic Chemistry

Volumn , Issue 5, 2005, Pages 939-947

  Taddei, David ^a   Slawin, Alexandra M Z ^a   Woollins, J Derek ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Antitumor agents; Enzymes; Inhibitors; Nitrogen heterocycles; Template synthesis

Indexed keywords

2 (BENZYLSULFANYL) 6 CHLORO 9 ISOPROPYLPURINE; 2,6 DIAMINOPURINE; ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR; ENZYME INHIBITOR; HETEROCYCLIC AMINE; PURINE DERIVATIVE; PURVALANOL A; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL CYCLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; ENZYME INHIBITION; INFRARED SPECTROSCOPY; OXIDATION; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

EID: 15044345660     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ejoc.200400748     Document Type: Article

References (25)

1. A. Murray, Chem. Biol. 1994, 1, 191-195.
2. D. T. Hung, T. F. Jamison, S. L. Schreiber, Chem. Biol. 1996, 3, 623-639.
3. W. Wells, Chem. Biol. 1997, 4, 631-632.
4. T. Sielecki, J. Boylan, P. Benfield, G. Trainor, J. Med. Chem. 2000, 43, 1-18
5. L. Meijer, Trends Cell Biol. 1996, 6, 393-397.
6. W. De Azevedo, Jr., H.-J. Mueller-Dieckmann, U. Schulze-Gahmen, P. J. Worland, E. Sausville, S.-H. Kim, Proc. Natl. Acad. Sci. USA 1996, 93, 2735-2740.
7. Y. T. Chang, N. S. Gray, G. R. Rosania, D. P. Sutherlin, S. Kwon, T. C. Norman, R. Sarohia, M. Leost, L. Meijer, P. G. Schultz, Chem. Biol. 1999, 6, 361-375.
8. H. N. Bramson, J. Corona, S. T. Davis, S. H. Dickerson, M. Edelstein, S. V. Frye, R. T. Gampe, Jr., P. A. Harris, A. Hassell, W. D. Holmes, R. N. Hunter, K. E. Lackey, B. Lovejoy, M. J. Luzzio, V. Montana, W. J. Rocque, D. Rusnak, L. Shewchuk, J. M. Veal, D. H. Walker, L. F. Kuyper, J. Med. Chem. 2001, 44, 4339-4358.
9. P. Imbach, H. G. Capraro, P. Furet, H. Mett, T. Meyer, J. Zimmermann, Bioorg. Med. Chem. Lett. 1999, 9, 91-96.
10. M. Legraverend, O. Ludwig, E. Bisagni, S. Leclerc, L. Meijer, Bioorg. Med. Chem. Lett. 1998, 8, 793-798.
11. M. Legraverend, O. Ludwig, E. Bisagni, S. Leclerc, L. Meijer, N. Giocanti, R. Sadri, V. Favaudon, Bioorg. Med. Chem. 1999, 7, 1281-1293.
12. D. Taddei, P. Kilian, A. M. Z. Slawin, J. D. Woollins, Org. Biomol. Chem. 2004, 2, 665-670.
13. V. Brun, M. Legraverend, D. S. Grierson, Tetrahedron 2002, 58, 7911-7923.
14. C. L. Gibson, S. La Rosa, C. J. Suckling, Org. Biomol. Chem. 2003, 1, 1909-1918.
15. M. Y. Chu-Moyer, W. E. Ballinger, D. A. Beebe, J. B. Coutcher, W. W. Day, J. Li, B. L. Mylari, P. J. Oates, R. M. Weekly, J. Med. Chem. 2002, 45, 511-528.
16. B. Zacharie, L. Gagnon, G. Attarde, T. P. Conolly, Y. St-Denis, C. L. Penney, J. Med. Chem. 1997, 40, 2883-2894.
17. B. Masjost, P. Ballmer, E. Borroi, G. Zurcher, F. K. Winkler, R. Jakob-Roetne, F. Diederich, Chem. Eur. J. 2000, 6, 971-982.
18. H. P. Daskalov, M. Sekine, T. Hata, Bull. Chem. Soc. Jpn. 1981, 54, 3076-3083.
19. M. Morris, B. Uznanski, Can. J. Chem. 1981, 59, 2601-2606.
20. A. Toyota, N. Katagiri, C. Kaneko, Heterocycles 1983, 36, 1625-1630.
21. M. Legraverend, P. Tunnah, M. Noble, P. Ducrot, O. Ludwig, D. Grierson, M. Leost, L. Meijer, J. Endicott, J. Med. Chem. 2000, 43, 1282-1292.
22. K. Banks, J. Am. Chem. Soc. 1944, 66, 1127-1130.
23. N. K. Lembicz, S. Grant, W. Clegg, R. J. Griffin, S. L. Health, B. T. Holding, J. Chem. Soc., Perkin Trans. 1 1997, 185-186.
24. M. Ashwell, C. Bleasdale, B. T. Golding, I. K. O'Neill, J. Chem. Soc., Chem. Commun. 1990, 955.
25. SHELXTL, Bruker AXS Madison, 2001.